Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

1 paper

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant

Songbai Xu, Xiaoxiao Yao, Bingjin Li, Ranji Cui, Cuilin Zhu, Yao Wang, et al.
Frontiers in Pharmacology Summary & key facts 2022 50 citations

Major depressive disorder is a serious illness. Researchers reviewed how ketamine — a drug that blocks a brain receptor called the NMDA receptor — can lift depression symptoms quickly and for a sustained time in people and in animals. They describe possible ways ketamine works: it may boost another type…

Neuroscience and Neuropharmacology Research Treatment of Major Depression Tryptophan and brain disorders Ketamine
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.